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~ Elevated Plasma Angictensin-Convertlng Enzyme 
Levels Are Associated With Myocardial Infarction 
in Young Subjects Without Risk Factors, 
Independently of Coronary Artery Disease, and ow 
Inesrtion/Defation Gene Polymorphlsm 
Ravio R~chini, Gtueeppe Stsffenino, Antonio Dellavalle, 
Teronzio Camilla 1 Alberto Piazza 2, Gabriella Benetton ~, Ping Mafullo 2 
Eugento Uslenghi. Cardiac Catheterization Us#, University of Tudn, I~aly; 
1 Laboratory for CllnicaIBiochemistiy, Copedale S. Croon, Cuneo, University 
of Turin, ifaly; = Institute of Human Genetics, University of Tut~n, Ita~ 
Elevated plasma anglotansin-convsrting enzyme (ACE) levels, and D/D ACE 
genatype have been proposed as risk-factors for myocardial infarction (MI). 
Of 1150 patients (p) wfth MI and no ACE-Inh~ifor treatment undergoing 
coronary a, tsriogrephy in our center during 24 months, 20 p [Group A]wera 
< = 40 year-old and had no conventional dsk factors (CRF) for MI [smoke, 
hypertension, diabetes, body mass index > 26 Kg/m2, Ape B > 1.25 g/L, Lp 
(a) > 20 g/L, fibfinogen > 300 g/L]; 30 p [Group B]were < - 40 year-old and 
had I or > CRR Basal plasma ACE levels were measured with a quantitative 
kinetic determination using FAPGG substrata. Amplification by polymerase 
chain reaction was used in the determination of ACE genotype. Mean (+ - 
SD) plasma ACE levels, and I/D genotype were as follows (percentages in 
brackets): 
No. ACE(U/L) D/D I/D I/I 
Group A 20 30 ~- 13 # 8 (40) 8 (40) 4 (20) 
Group B 30 194.11 # 10(33) 11 (37) 9(30) 
ep. 0.002; 95% c.i. 0.85 to 12 
A normal coronary anglogram (no stsnoals > 20% with Quantitative Coro- 
amy Anglography) was found in 16/20 p in group A vs. none in group B. 
In conclusion: young p with MI and no CRF seem to have higher plasma 
ACE levels than p with CRF. Coronary artery stanesas are often absent at 
angiography in these patients. No significant predominance of the D/D gano- 
type was observed in this limited population sample. The ronin-angiotsnsin 
system may contnloute to the risk of myocandial infarction, with no apparent 
effect on the development of coronary atherosclerosis. 
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~ - ~  Threatening or Manifest Reocclusion of the 
Infarct Artery in Acute Myocardial Infarction 
Treated With Primary PTCA: Outcome After 
Prolonged Autoperlusionballoon Catheter 
Treatment >_ 30 Minutes 
K. Emmerich, I.. Ulbifcht, I. Krakau, A. Bufe, H. Probst, H. G01ker. Heart 
Center Wuppertal, University of WdforVHerdeske, Germany 
Reeccluslon alter initially successful ropefiuslon of the infarct-ralated coro- 
nary artery ((RA) in acute myocardial infarction (AMI) induces a nearly thrse- 
fold increase of In-hospifat mortality compared to patients (pte) with open 
vessels, The elm of this study was to evaluate the impact of prolonged au- 
toperfualonballcon catheter (APBC) inflation of the IRA on acute and late 
(1S ± 11 months) outcome used in case of thrastaning/manifast reocolualon 
following severe dissuction of a reperfused vessel. Study population and 
charactedst/cs: From ¢2/89 to 10/94 309 pts were treated with primary PTCA 
in AMI within 12 hours of symptom onset. 35 pts.(11.3%) suffered threatening 
(TIMI II) or manifest (TIMI 0/1) reocclusion after initially successful (TIMI III) 
IRA recanallcation. 
Age Male CS Pr/or (%) MVDI" 11me onset of pain 
(years) lots) (%) CABG t MP (%) to recanalication 
58 4.11 32 11 6 26 40 202 4- 90 rain. 
:l:corona,y artery bypass grafting. CS = cardiognnlo shock; "MI - myocardial Infarction; 
tMVD - multk'essel disease 
in 52=/o threatening/manifeet reecclusion ocoured in the fight coronary 
artery [p = 0.326]. APBC used was larger in diameter compared to the 
standard balloon (p ,, 0.0001), APBC inflation pressure lower (p = 0.0001) 
and APBC inflation time longer (mean 35 rain.) [p = 0.0001]. 
Results (%): 
TIMI III- Steals" 30 day EF Q late 
flow (IRA) reooduslon mortallly . (%) restenosla mortality 
94.3 5.7 2.9 5.8"* ÷10 $0,8 O 
• coronary stem after APBC.fa[lura; °'pla in C5 on edmlsalon;~EF - left ventrlcufar elec- 
tion fraction [increase during follow up (p. 0.001)]; 
Conclusions: Prolonged Inflation with an APBC is a safe end successful 
treatment of threatening or manifest reocclualon of the IRA. Improvement of 
EF is significant and restenoals rate is comparable to those in elective PTCA. 
APBC technique seems to be a preferable approach to manage bailout 
s~ations during primary PTCA. 
~ Complementary Beneficial Effect of Early and 
Late Treatment With ACE-Inhlbltora In Acute 
Myocardial Infarction. A Model Based on GISSI-3 
and AIRE Results 
Glullo Zuanet11, Robarto LatiN, Ndo P. Mnggionl, Eugenic Sanforo, 
MafiaGrazla Frenzasl, Giannl Tognonl, on behalf of the GISSI-3 
Invesflgatom. ANMCO and Istitufo M. Negri, Italy 
Several studies documented the beneficial effect of ACE-inhibifors (ACE-i) 
in pta with acute myocardial infarction (AM|). However, selection of pta and 
timing of ACE-I treatment are still debated. We quantified the beneficial effect 
of (a) an early (within 24 hr) use of ACE-I in hemodynamlcally stable pta 
~b) a late use of ACE-Inhlbifors in selected pte and (o) combination of these 
approaches, in 4 different ypes of pts with AMI depending on ~hsence or 
presence of symptoms of cardiac dysfunction at enby (Killlp class > 1) and 
during evolving AMI (CHF+). Actual data on effect of ACE-i were derived 
from GISSI-3 and AIRE studies. The mean time of enrollment of pts in AIRE 
(5 days) was taken as cut-off between early (0-5 days) and late (5 days- 
onward) treatment. The calculated beneficial effect of ACE-! on 8 months 
roortality is as follows 
Clinical status At army Killlp I Kllllp I Killlp > 1 K]llip > 1 
ofpt $ ~ $ ~ 
ln-hosptlal CHF- CHF+ CHF- CHF+ 
% Of AMI pta randomized 74% 8.5% 5% 9% 
within 24 hrs" 
Lives saved Early" 4 4 12 12 
at 0 months/ Late" ~ 21 ~ 21 
1000 ~ts Eady + late 4 25 12 33 
*data derived from GISSI-3, "data dorive{I from AI ~.'-" 
In conclusion, date from a model based on large clinical trials Indicate that 
an early treatment with ACE-i of all hemodynamtcally stable pts with acute 
MI followed by a late targeted treatment of 10ts with symptoms of congestive 
heart failure is able to maximize the benefit of ACE-i in pta with evolving ML 
Is Thrombolyt l¢ Therapy Underuesd In Women 
With Acute Myocardial  In farct ion In Clinical 
Practice? 
Udo Burczyk, J6rg Ruetige, Rudolf Schlale, Armln Koch 1, Dietrich Boppert, 
Jechen Sengas, Herzzentrum Ludwigshafen on behalf of the ALKK Study 
Group. I ZMBT Heldelberg, Germany 
Recent reports have called attention to differences in the therapeutic ap- 
proach of physicians to men end women with acute myocardial infarction 
(AMI). We evaluate the sex-speclflc characteristics of these patients and the 
Influence of gender on dally clinical treatment of AMI. 
Methods: "The 50-Minutes Myocardial Infarction Project" is s mulflcenter 
nationwide study of current treatment of AMI which includes 136 hospitals 
in Germany. During a 27-month pedod 14 980 patients with proven trans. 
mural AMI were enrolled and lysls rate (LR), prehospifal delay, absolute and 
relative contraindications to thrombolyals and the diagnostic accuracy of the 
electrocardiogram upon admission were studied. 
Results: 
Men (n - 10 209) Women (n = 4 771) 
Age (mean/yr) 82 71 * 
Lysia rate (%) 58 42" 
Pmhospital delay (medianJh) 2.6 3.5" 
Contraindlcatlons (%) 22 23 
Diagnostic ECG (%) 72 71 
• p < 0.05 
A multivariate analysis of 15 factors associated with indication to thmm- 
bolyals showed that female sex was an independent predictor of a lower LR 
(Odds ratio: 0.8; g5%-confidence interval: 0.7-0.9). 
